• In January 2026, the U.S. Department of Energy selected Centrus Energy for a US$900 million task order to expand its Piketon, Ohio uranium enrichment facility for commercial-scale High-Assay, Low-Enriched Uranium (HALEU) and additional Low-Enriched Uranium production, supporting thousands of jobs across Ohio, Tennessee, and a nationwide supplier network.
• This award reinforces Centrus Energy’s role as a key U.S. uranium enricher at the center of efforts to rebuild domestic nuclear fuel supply for clean energy, energy security, and national security needs.
• We'll now examine how this US$900 million Department of Energy award and HALEU capacity expansion could reshape Centrus Energy's investment narrative.

These 16 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.

Centrus Energy Investment Narrative Recap

To own Centrus Energy, you need to believe that demand for domestic nuclear fuel and advanced reactor fuels will support sustained use of its enrichment capacity, and that Centrus can execute its expansion plans. The US$900 million Department of Energy task order directly supports the key short term catalyst of scaling HALEU and additional LEU production, while also heightening the main risk around delivering complex projects on time and on budget.

Among recent updates, the December 2025 move to begin domestic centrifuge manufacturing in Piketon stands out alongside the new DOE award, because both speak to Centrus’ ability to build and operate the infrastructure needed to turn its backlog and HALEU opportunity into actual production and revenue.

Yet behind the government funding and growth plans, investors should be aware of the execution and cost overrun risk that...

Centrus Energy’s narrative projects $640.9 million revenue and $70.3 million earnings by 2028.

Uncover how Centrus Energy's forecasts yield a $279.73 fair value, a 6% downside to its current price.

Exploring Other Perspectives

Fair value estimates from 9 Simply Wall St Community members span roughly US$96 to US$390 per share, showing very different opinions on Centrus’ potential. Against that wide range, the thesis that domestic enrichment capacity and HALEU build out could be a key earnings catalyst highlights why you may want to compare several viewpoints before deciding how this stock fits your portfolio.

Explore 9 other fair value estimates on Centrus Energy - why the stock might be worth as much as 31% more than the current price!

Build Your Own Centrus Energy Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Centrus Energy research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Centrus Energy research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Centrus Energy's overall financial health at a glance.

Seeking Other Investments?

Our top stock finds are flying under the radar-for now. Get in early:

• Explore 29 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• Find companies with promising cash flow potential yet trading below their fair value.
• AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.